Cargando…
Continuous use of metformin can improve survival in type 2 diabetic patients with ovarian cancer: A retrospective study
Evidence indicates that type 2 diabetes may stimulate the initiation and progression of several types of cancer. Metformin, a drug most commonly used to treat type 2 diabetes, may inhibit cancer cell growth and reduce the risk of cancer. However, evidence of the antitumor effects of metformin on ova...
Autores principales: | Wang, Shan-Bing, Lei, Kai-Jian, Liu, Jia-Pei, Jia, Yu-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521948/ https://www.ncbi.nlm.nih.gov/pubmed/28723808 http://dx.doi.org/10.1097/MD.0000000000007605 |
Ejemplares similares
-
No association between metformin use and survival in patients with pancreatic cancer: An observational cohort study
por: Frouws, Martine A., et al.
Publicado: (2017) -
Melanotic neuroectodermal tumor of infancy successfully treated with metformin: A case report
por: Liang, Yu, et al.
Publicado: (2020) -
Multiple genetic variants predict the progression-free survival of bevacizumab plus chemotherapy in advanced ovarian cancer: A retrospective study
por: Gao, Jie, et al.
Publicado: (2021) -
Nomogram predicting long-term overall survival and cancer-specific survival of lip carcinoma patients based on the SEER database: A retrospective case–control study
por: Zhao, Rui, et al.
Publicado: (2019) -
Surgery of the primary tumor improves survival in women with stage IV breast cancer in Southwest China: A retrospective analysis
por: Xie, Yuxin, et al.
Publicado: (2017)